Clinical trial Recruiting at 4 sites Observational Ages 18 and up

Blood test for early diagnosis of colorectal cancer

Official title: Development and Validation of a Blood Test for Early Diagnosis of Colorectal Cancer Based on Molecular Markers and Risk Factors Identified With Artificial Intelligence Tools

Run by Advanced Marker Discovery S.l. · NCT06889883 · Data updated 2026-11-12

This study is testing a new blood test to see if it can help find colorectal cancer and advanced polyps earlier in people who are at risk.

More Colorectal Carcinoma trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment510 (estimated)
SponsorAdvanced Marker Discovery S.l.
Industry-sponsored
Drugs / interventionschemotherapy
Locations9 sites (Zaragoza, Aragon and 8 other locations)
StatusRecruiting
StartedJune 6, 2023
Main results expectedDecember 31, 2025
Study endsDecember 31, 2025
Registry record updatedOctober 1, 2025
Trial IDNCT06889883 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults over 18 who are scheduled for colonoscopy or surgical resection due to suspected colorectal cancer.

Probably not a fit

Patients with a history of cancer in the past 5 years or those with certain benign conditions like non-advanced adenomas will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to develop and validate a blood test that combines molecular markers in plasma with risk factors and clinical data to improve early diagnosis of colorectal cancer and advanced adenomas. It involves a multicenter, case-control design where patients undergoing colonoscopy or surgical resection will be compared to healthy individuals. The goal is to create an optimized algorithm that enhances the accuracy of early detection.

Why it matters

Potential benefit: If successful, this blood test could lead to earlier diagnosis of colorectal cancer, potentially improving patient outcomes and survival rates.

How similar studies have gone: While there have been studies exploring blood tests for cancer detection, this specific approach combining molecular markers and clinical data is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients over the age of 18 who are able to understand the participant information and sign the informed consent.
* Patients who are going to undergo colonoscopy or surgical resection for tumor (CRC).

Exclusion Criteria:

* Patients who had developed any type of cancer in the 5 years prior to their participation in this study.
* Patients who have received previous chemotherapy or radiotherapy.
* Patients diagnosed with non-advanced adenomas, serrated polyps, Familial Adenomatous Polyposis or Lynch Syndrome.
* Patients with inadequate bowel preparation for colonoscopy.
* Patients who have undergone colonoscopy/polipectomy in the previous 5 years.
* Patients with hemolyzed plasma.

Where it's running

  • Hospital Clinico Universitario Lozano Blesa
    Zaragoza, Aragon, Spain
    Recruiting
  • Hospital Universitario de Cruces
    Bilbao, Basque Country, Spain
    Recruiting
  • Hospital Universitario de Salamanca
    Salamanca, Castille and León, Spain
    Recruiting
  • Hospital Centro Médico de Asturias
    Oviedo, Principality of Asturias, Spain
    Recruiting
  • Policlinica Gipuzkoa Hospital
    Donostia / San Sebastian, Basque Country, Spain
    Completed
  • Hospital Universitario Marques de Valdecilla
    Santander, Cantabria, Spain
    Terminated
Show 3 more locations
  • Hospital Sant Rafael
    Barcelona, Catalonia, Spain
    Completed
  • Hospital Universitario Vall d' Hebron
    Barcelona, Catalonia, Spain
    Completed
  • MD Anderson Cancer Centre
    Madrid, Madrid, Spain
    Active not recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.